Research levels of the papers in the network models
| A. Biological phenomenon | Papers investigating CRISPR/Cas as bacterial immune systems; the interactions of their component in bacteria or archaea, and/or the molecular, ecological, or evolutionary interactions of these systems with the bacteriophage viruses. |
| B. Developments or improvements of CRISPR/Cas technologies | These papers report discoveries of alternative CRISPR/Cas genome editing systems that could be more efficient, more versatile, or easier to use; investigations aimed to overcome the technical difficulties to apply the technology in different organisms; or investigations reporting molecular mechanisms that can be used to modulate the activity of Cas enzymes. |
| C. Other | Papers in which CRISPR/Cas is not the central object of investigation but is an instrument to identify or analyze the role of specific genes in normal or pathological biological processes; papers reporting applications of CRISPR/Cas in biomedicine, food systems, environmental systems, or industrial biotechnology; or papers reporting the ethical or societal implications of CRISPR/Cas technologies. |
| A. Biological phenomenon | Papers investigating CRISPR/Cas as bacterial immune systems; the interactions of their component in bacteria or archaea, and/or the molecular, ecological, or evolutionary interactions of these systems with the bacteriophage viruses. |
| B. Developments or improvements of CRISPR/Cas technologies | These papers report discoveries of alternative CRISPR/Cas genome editing systems that could be more efficient, more versatile, or easier to use; investigations aimed to overcome the technical difficulties to apply the technology in different organisms; or investigations reporting molecular mechanisms that can be used to modulate the activity of Cas enzymes. |
| C. Other | Papers in which CRISPR/Cas is not the central object of investigation but is an instrument to identify or analyze the role of specific genes in normal or pathological biological processes; papers reporting applications of CRISPR/Cas in biomedicine, food systems, environmental systems, or industrial biotechnology; or papers reporting the ethical or societal implications of CRISPR/Cas technologies. |